# ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

Study · id `cardio:ct-nct01460446` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01460446](<https://clinicaltrials.gov/study/NCT01460446>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01460446

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 218 participants.

## Technical summary

Registry record NCT01460446. Randomized; no masking; primary purpose diagnostic. Start 2011-10 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2014-02-06.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 218 participants (enrolled count; ClinicalTrials.gov record NCT01460446, source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)
- Start date: 2011-10 (registry gives no type) (ClinicalTrials.gov record NCT01460446, source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01460446, source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)
- Completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01460446, source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)
- Results first posted: 2014-02-06 (ClinicalTrials.gov record NCT01460446, source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)
- Countries: Germany; United Kingdom (ClinicalTrials.gov record NCT01460446, source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01460446-2014-02-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?
- Acronym: ABACUS
- Condition: Diabetes Mellitus, Type 1
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Aviva Expert blood glucose meter
- Intervention (Device): Aviva Nano blood glucose meter
- Lead sponsor: Hoffmann-La Roche
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Hoffmann-La Roche (`cardio:org-hoffmann-la-roche`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? \[NCT01460446\] (`cardio:pubmed-23062116`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a0ab6299951b59e968817b162ac04426216038772eb56b5441bced923025c894
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
